HIPEC Surgery Mumbai: Procedure, Benefits, Candidates and Recovery
Peritoneal cancer occurs when cancer affects the lining of the abdominal cavity and may develop from cancers originating in the colon, appendix, rectum, stomach, ovary, or other organs. When cancer has spread within the peritoneal cavity, treatment may require a specialized combination of surgery and chemotherapy. HIPEC surgery mumbai is an advanced treatment approach in which visible tumors are surgically removed and heated chemotherapy is circulated directly inside the abdomen to target remaining microscopic cancer cells.
What Is HIPEC?
HIPEC stands for Hyperthermic Intraperitoneal Chemotherapy. Unlike conventional chemotherapy, which is usually delivered through the bloodstream, HIPEC involves administering heated chemotherapy directly into the abdominal cavity during surgery.
The HIPEC procedure generally begins with cytoreductive surgery, during which the surgeon removes visible cancer deposits from the abdomen. Once the visible disease has been removed as thoroughly as possible, a specially prepared chemotherapy solution is heated and circulated inside the abdominal cavity. According to the reference information, the chemotherapy solution is circulated for approximately 90 minutes before being removed.
The combination of cytoreductive surgery and heated intraperitoneal chemotherapy is designed to address both visible tumor deposits and microscopic cancer cells that may remain after surgery.
How Does HIPEC Work?
HIPEC treatment consists of two important components: cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy.
During cytoreductive surgery, the surgeon carefully examines the abdominal cavity and removes visible tumor deposits. Depending on the extent and location of disease, this can be a complex operation involving removal of affected tissues or organs.
After the visible cancer has been removed, heated chemotherapy is introduced into the abdominal cavity. The solution is circulated so that the chemotherapy can come into contact with the surfaces where microscopic cancer cells may remain.
Heating the chemotherapy is an important part of the HIPEC technique. The treatment is designed to deliver a concentrated chemotherapy exposure directly to the abdominal cavity rather than relying solely on systemic drug delivery.
Which Cancers Can Be Treated With HIPEC?
HIPEC is primarily considered for selected cancers involving the peritoneal surface. These may include certain colorectal cancers, appendiceal cancers and other malignancies that have spread to the peritoneum.
However, HIPEC is not appropriate for every patient with advanced cancer. Patient selection depends on factors such as the type of cancer, extent of peritoneal spread, overall health, previous treatments, tumor distribution, and whether the visible disease can be adequately removed.
A specialist evaluation is therefore essential before considering this treatment.
Cytoreductive Surgery and HIPEC
Cytoreductive surgery is a major component of the HIPEC treatment approach. Its objective is to remove as much visible tumor as possible from the abdominal cavity. Dr. Chintamani Godbole’s profile specifically lists cytoreductive surgery and HIPEC among his areas of expertise.
The complexity of this surgery means that patients should be assessed by a surgeon with specialized training in colorectal and peritoneal surface oncology. A detailed evaluation helps determine whether complete or near-complete removal of visible disease is technically possible and whether HIPEC is appropriate.
Who May Be a Candidate for HIPEC?
HIPEC may be considered for carefully selected patients whose cancer has spread to the peritoneal surface. The decision is generally based on several clinical factors, including:
Primary cancer type
Extent of peritoneal disease
Location and distribution of tumor deposits
General health and fitness for major surgery
Previous chemotherapy or cancer treatment
Whether visible cancer can be removed surgically
Overall treatment goals
Because every cancer behaves differently, the suitability of HIPEC must be determined on an individual basis after imaging, pathology review, clinical examination, and multidisciplinary assessment where appropriate.
Benefits and Considerations of HIPEC
One of the key features of HIPEC is the direct administration of chemotherapy into the abdominal cavity. The reference material describes its purpose as targeting cancer cells that may remain after visible tumors have been removed.
However, HIPEC is a complex treatment rather than a simple chemotherapy procedure. Cytoreductive surgery can be extensive, and recovery may take time. Potential complications depend on the extent of surgery, organs involved, chemotherapy used, and the patient’s general health.
Patients should discuss potential benefits, limitations, risks, expected hospitalization, recovery, and alternative treatment options with their treating cancer team before making a decision.
Why Choose Dr. Chintamani Godbole for HIPEC Care?
Dr. Chintamani Godbole is a dedicated gastrointestinal and colorectal surgeon with a special interest in colorectal surgery and peritoneal surface oncology. His qualifications include MBBS and MS in General Surgery, followed by DNB in Surgical Gastroenterology. He also holds MRCS and FRCS from the Royal College of Surgeons of Edinburgh.
His professional training includes extensive experience in the United Kingdom, including fellowships in minimally invasive colorectal surgery, colorectal cancer surgery, peritoneal cytoreductive surgery, and HIPEC. He also trained at the Basingstoke Peritoneal Malignancy Institute, a specialist centre for colorectal and peritoneal cancer surgery.
Dr. Godbole has more than 10 years of experience and reports performing over 200 minimally invasive colorectal surgeries and more than 50 cytoreductive surgeries and HIPEC procedures for advanced peritoneal cancers. His expertise also includes robotic and laparoscopic colorectal surgery, sphincter-preserving rectal cancer surgery, trans-anal minimally invasive surgery, and surgery for inflammatory bowel disease.
For patients seeking a Best Doctor for Gastroenterology in Mumbai, his focused expertise in colorectal and peritoneal surface oncology can be particularly relevant when advanced surgical treatment is being considered.
A Patient-Centred Approach to Advanced Cancer Surgery
HIPEC treatment requires careful planning before surgery and close monitoring afterward. Patients may need consultations involving surgery, oncology, radiology, pathology, anesthesia, and other specialists depending on their diagnosis.
Dr. Godbole emphasizes personalized communication with patients and relatives as part of his clinical approach. His listed hospital affiliations include Jaslok Hospital, Sir H. N. Reliance Foundation Hospital, Breach Candy Hospital, and Wockhardt Hospitals in Mumbai.
For patients considering care with a Colorectal Surgeon in Mumbai, discussing the complete treatment pathway during consultation can help them understand the purpose of surgery, expected recovery, and the role of chemotherapy.
What Is Recovery After HIPEC Like?
Recovery after cytoreductive surgery and HIPEC varies considerably between patients. Because the procedure can involve extensive abdominal surgery, hospitalization and recovery may be considerably longer than after routine minimally invasive procedures.
During recovery, the medical team monitors bowel function, nutrition, pain, wound healing, fluid balance, and other aspects of postoperative health. Gradual mobilization and appropriate nutritional support may form an important part of recovery.
The exact recovery timeline depends on the extent of surgery, organs or tissues treated, patient’s general health, and whether complications occur. Patients should follow their surgical team’s instructions regarding physical activity, diet, medications, wound care, and follow-up appointments.
Why Specialist Evaluation Matters
HIPEC is a highly specialized cancer treatment and should not be considered solely because a patient has advanced abdominal cancer. Careful assessment is necessary to determine whether the cancer pattern and patient’s overall condition make cytoreductive surgery and HIPEC appropriate.
A consultation with a surgeon experienced in peritoneal surface malignancy can help patients understand their diagnosis and explore appropriate treatment options.
Schedule a Consultation With Dr. Chintamani Godbole
If you or a family member has been diagnosed with peritoneal surface cancer or has been advised to explore cytoreductive surgery and HIPEC, a specialist consultation can provide clarity about the available treatment pathway.
Dr. Chintamani Godbole provides specialized colorectal and peritoneal oncology care at Gadre Hospital in Dadar East, Mumbai. His experience in cytoreductive surgery and HIPEC enables patients to discuss advanced surgical treatment with a specialist focused on colorectal and peritoneal diseases.
Call: 81087 91470
Frequently Asked Questions
1. What does HIPEC stand for?
HIPEC stands for Hyperthermic Intraperitoneal Chemotherapy. It involves circulating heated chemotherapy directly inside the abdominal cavity after visible tumors have been surgically removed.
2. Is HIPEC suitable for every patient with peritoneal cancer?
No. HIPEC is considered only for selected patients. Cancer type, extent of peritoneal disease, overall health, previous treatment, and whether visible tumors can be adequately removed are among the factors considered.
3. How long does the chemotherapy part of HIPEC take?
The reference treatment information states that the heated chemotherapy solution is circulated in the abdomen for approximately 90 minutes before being removed. The total operation takes considerably longer because cytoreductive surgery is performed as part of the treatment.
4. Who performs HIPEC surgery at Gadre Hospital?
Dr. Chintamani Godbole is a gastrointestinal and colorectal surgeon with specialized training in peritoneal surface oncology, cytoreductive surgery, and HIPEC. His profile reports experience with more than 50 cytoreductive surgeries and HIPEC procedures for advanced peritoneal cancers.
Comments